1. Home
  2. ARTL vs NCPL Comparison

ARTL vs NCPL Comparison

Compare ARTL & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$1.75

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

NCPL

Netcapital Inc.

HOLD

Current Price

$0.87

Market Cap

3.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTL
NCPL
Founded
2011
1984
Country
United States
United States
Employees
7
20
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
3.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ARTL
NCPL
Price
$1.75
$0.87
Analyst Decision
Hold
Analyst Count
2
0
Target Price
N/A
N/A
AVG Volume (30 Days)
163.7K
6.2M
Earning Date
05-13-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$739.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.94
$0.31
52 Week High
$28.60
$8.75

Technical Indicators

Market Signals
Indicator
ARTL
NCPL
Relative Strength Index (RSI) 36.30 85.92
Support Level $1.62 $0.62
Resistance Level $1.96 $2.55
Average True Range (ATR) 0.23 0.09
MACD -0.02 0.06
Stochastic Oscillator 31.32 92.50

Price Performance

Historical Comparison
ARTL
NCPL

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

Share on Social Networks: